DOD Biotech Public Company Limited

SET:DOD-R Stock Report

Market Cap: ฿756.7m

DOD Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Torlarp Chaiyachow

Chief executive officer

฿315.7k

Total compensation

CEO salary percentagen/a
CEO tenure2yrs
CEO ownershipn/a
Management average tenure3.5yrs
Board average tenure5.5yrs

Recent management updates

Recent updates


CEO

Torlarp Chaiyachow

2yrs

Tenure

฿315,705

Compensation

Mr. Torlarp Chaiyachow is Acting CEO & Acting Executive Chairman of DOD Biotech Public Company Limited from December 01, 2022.


Leadership Team

NamePositionTenureCompensationOwnership
Torlarp Chaiyachow
Acting CEO & Acting Executive Chairman2yrs฿315.71kno data
Suwarin Konthong
CFO & Executive Director5yrs฿668.91kno data
Nattawat Phetthai
Chief Accountant5.1yrsno datano data
Watcharaporn Klabwongsa
Chief Administration Officerno datano datano data
Darunee Kongphakdee
Chief Marketing Officer2yrsno datano data
Arachaporn Boonnkerd
Company Secretaryno datano datano data
Supaporn Kaewyai
Account Controllerno datano datano data

3.5yrs

Average Tenure

Experienced Management: DOD-R's management team is considered experienced (3.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Torlarp Chaiyachow
Acting CEO & Acting Executive Chairman2yrs฿315.71kno data
Suwarin Konthong
CFO & Executive Director5.5yrs฿668.91kno data
M.L. Subphaso
Advisor to the Board2.8yrs฿120.00kno data
Dusit Chongsutthanamanee
Independent Vice Chairman9yrs฿1.15mno data
Pongtep Thithapand
Independent Director9yrs฿670.00kno data
Apaporn Kosolkul
Independent Chairman of the Board9yrs฿1.09mno data
Porntep Siriwanarangsun
Independent Directorless than a yearno datano data

5.5yrs

Average Tenure

61yo

Average Age

Experienced Board: DOD-R's board of directors are considered experienced (5.5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 05:23
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DOD Biotech Public Company Limited is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wilasinee BoonmasungsongGloblex Securities Co. Ltd.
Hathaichanoke MoonwongPhillip Securities (Thailand) PCL
Apichat PoobunjirdkulTisco Securities Co. Ltd.